1 Department of Preventive Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
2 Department of Internal Medicine, Fukuoka University School of Medicine, Fukuoka, Japan.
3 Self Defense Forces Fukuoka Hospital, Fukuoka, Japan.
4 Self Defense Forces Kumamoto Hospital, Kumamoto, Japan.
Correspondence: Tomomi Marugame, Department of Preventive Medicine, Faculty of Medical Sciences, Kyushu University, 311 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. E-mail: marugame{at}phealth.med.kyushu-u.ac.jp
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Methods Study subjects were middle-aged Japanese men: 177 cases of colorectal adenomas and 192 controls with normal total colonoscopy. Statistical adjustment was made for hospital, rank in the Self Defense Forces, alcohol use, smoking, and body mass index.
Results Plasma folate levels were slightly lower in adenoma cases than in controls. Adjusted odds ratio (OR) for high (>5.50 ng/ml) versus low plasma folate levels was 0.72 (95% CI: 0.461.14). As compared with subjects with the CC or CT genotype having low plasma folate levels, those with the TT genotype showed a decreased risk of colorectal adenomas when they had high levels of plasma folate (adjusted OR = 0.58, 95% CI: 0.211.61), and an increased risk when they had low folate levels (adjusted OR = 2.13, 95% CI: 0.825.54). There was no clear relation between plasma folate and colorectal adenomas among those with the CC or CT genotype.
Conclusions The findings suggest an interaction between folate and the MTHFR genotype on colorectal adenomas.
Accepted 24 June 2002
Much attention has recently been paid to a possible protective effect of folate in colorectal carcinogenesis. High dietary intake of folate and high levels of plasma or serum folate have been associated with decreased risk of colorectal cancer and adenomas.1,2 Methylenetetrahydrofolate reductase (MTHFR) plays a pivotal role in folate metabolism, and MTHFR C677T polymorphism determines the activity of the enzyme.3 The MTHFR mutant homozygous TT genotype was shown to be associated with a decreased risk of colorectal cancer among those with high folate intake.1,2 On the other hand, studies of colorectal adenomas reported an increased risk associated with the MTHFR TT genotype when folate intake was low and when red blood cell (RBC) or plasma folate levels were low.46
Previously, we reported that the MTHFR polymorphism was unrelated to colorectal adenoma but there was a small increase in risk for the combination of TT genotype and high alcohol consumption.7 In this study, we examined the association between plasma folate levels and colorectal adenomas by MTHFR genotype in an Asian population.
![]() |
Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
After an overnight fast, a sample of 7 ml of venous blood was taken for the purpose of research with written informed consent. The MTHFR genotype was determined by the polymerase chain reaction/restriction fragment length polymorphism method, as described previously.7 Plasma folate concentrations were determined by the chemiluminescent enzyme immunoassay at an external laboratory (CRC, Inc., Fukuoka, Japan) using commercial reagents (Bayer Medical Co Ltd., East Walpole, MA, USA). A self-administered questionnaire ascertained alcohol use, smoking habit, and other lifestyle characteristics.8
Comparison of plasma folate levels was done by t-test following analysis of covariance. Because the distribution of plasma folate levels was skewed to the right, the log-transformed values were used. Logistic regression analysis was used to calculate odds ratios (OR) and 95% CI. Plasma folate levels were dichotomized at the lower tertile (5.50 ng/ml) in the distribution of the controls; this cutoff point was determined a priori so as to distinguish a group with low folate levels. Statistical adjustment was made for hospital, rank in the SDF (three classes), alcohol use (never, past, and current drinking with a consumption of <30, 3059, or 60 ml of alcohol per day), smoking (0, 1399, 400799, and
800 cigarette-years), and body mass index (kg/m2). Age was not taken into account because the age range was limited to 4755 years. The interaction was evaluated by a likelihood ratio test. All statistical computations were done by SAS version 6.12 (SAS Institute, Inc., Cary, North Carolina, USA).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
The mechanisms underlying the differential associations between folate levels and colorectal adenomas by MTHFR genotype are rather complex. The folate metabolic pathway is involved in both DNA methylation and de novo nucleotide synthesis.13 In the presence of high folate levels, the low activity of MTHFR of the TT genotype may be advantageous in terms of nucleotide synthesis due to increased availability of 5,10-methylenetetrahydrofolate, the substrate of MTHFR. On the other hand, under low folate levels, DNA hypomethylation may be more likely to occur because methionine synthesis is decreased due to the lower levels of 5-methyltetrahydrofolate associated with the TT genotype.13
There were several limitations in the present study. A single measurement of plasma folate may not be a good indicator of long-term folate intake. Plasma folate levels are affected by the MTHFR genotypes, and thus the use of plasma folate may mask the true association between folate intake and adenomas. We did not ascertain the MTHFR A1298C polymorphism, which is also associated with the enzyme activity9 and may modify the folateadenoma relation. Finally, it should be noted that the study subjects were men who had served in the SDF until retirement, and it may be difficult to generalize the present findings to all Japanese men.
KEY MESSAGES
|
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
2 Ma J, Stampfer MJ, Giovannucci E et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997;57:1098102.[Abstract]
3 Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2000;130:12932.
4 Ulrich CM, Kampman E, Bigler J et al. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev 1999;8:65968.
5 Levine AJ, Siegmund KD, Ervin CM et al. The methylenetetrahydrofolate reductase 677CT polymorphism and distal colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2000;9:65763.
6 Ulvik A, Evensen ET, Lien EA et al. Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am J Med Genet 2001;101:24654.[CrossRef][ISI][Medline]
7 Marugame T, Tsuji E, Inoue H et al. Methylenetetrahydrofolate reductase polymorphism and risk of colorectal adenomas. Cancer Lett 2000;151:18186.[CrossRef][ISI][Medline]
8 Kono S, Handa K, Hayabuchi H et al. Obesity, weight gain and risk of colon adenomas in Japanese men. Jpn J Cancer Res 1999; 90:80511.[ISI][Medline]
9 van der Put NM, Gabreels F, Stevens EM et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998; 62:104451.[CrossRef][ISI][Medline]
Related articles in Int. J. Epidemiol.: